Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

Fig. 2

Matrix model of the proportion of patients with radiographic progression based on SJC28, CRP, and PhGA. Data are presented as % (95% confidence interval). Predicted probability of patients with radiographic progression represented by shading: green, < 22.0%; yellow, 22.0–32.0%; red, > 32.0%. CRP, C-reactive protein; SJC28, 28 swollen joint count; PhGA, physician global assessment; VAS, visual analogue scale

Back to article page